Dr Reddy’s Laboratories

Helsinn Healthcare in agreement with DRL

Read more

DRL launches esomeprazole magnesium delayed-release capsules

Read more

Dr Reddy’s, BioMarin settle patent litigation on Kuvan tablets

Read more

DRL partners with PanTheryx

Read more

Dr Reddy’s North America head quits

Read more

DRL recalls Rivastigmine Tartrate capsules from US

Read more

DRL launches Pramipexole dihydrochloride extended-release tablets in US

Read more

DRL in collaboration with Amgen in India

Read more

DRL posts consolidated revenues of Rs 37.6 billion, showing seven per cent growth YoY

Read more

DRL announces launch of memantine hydrochloride tablets, USP

Read more